Kolexia
Pourroy Bertrand Pharmacien
Pourroy Bertrand
Pharmacien
Hôpital La Timone
Marseille, France
206 Activités
891 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} COVID-19 Tumeurs osseuses Carcinome hépatocellulaire Lymphome B Déficit en dihydropyrimidine déshydrogénase Microangiopathies thrombotiques Lymphomes Inflammation Myosite

Collaborateurs

Voir plus
Villano-Gauthier Laurence
Villano-Gauthier Laurence
Hôpital La Timone, Marseille, France
Dupuy-Alessandra Christine
Dupuy-Alessandra Christine
Centre Hospitalier Toulon, Toulon, France
De Crozals Francoise
De Crozals Francoise
Institut Sainte Catherine, Avignon, France
Azouza Wakil
Azouza Wakil
Hp A. Tzanck Mougins Sophia Antipolis, Mougins, France

Industries

Voir plus
B3TSI
40 collaboration(s)
Dernière en 2021
Novartis
16 collaboration(s)
Dernière en 2023
Adliva
16 collaboration(s)
Dernière en 2021
Roche
15 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
Forecasting the potential impact of cell and gene therapies in France: projecting product launches and patients treated.
Frontiers in medicine   19 février 2024
Advanced therapy medicinal products' (ATMP) pharmaceutical circuit in France: Current situation and outlook.
Annales pharmaceutiques francaises   17 avril 2023
Severe Immune Checkpoint Inhibitor Toxicity Leading to ICU Admission in Patients With Solid Tumors.
American journal of clinical oncology   26 août 2022
Locally advanced or metastatic bladder cancer: Identification of barriers and levers of patients' pathway in France.
Bulletin du cancer   17 juin 2022
Cancer, immune suppression and Coronavirus Disease-19 (COVID-19): Need to manage drug safety (French Society for Oncology Pharmacy SFPO guidelines).
Cancer treatment reviews   23 juin 2020
Providing Oncology Pharmacy Services During the Coronavirus Pandemic: French Society for Oncology Pharmacy (Société Francaise de Pharmacie Oncologique SFPO) Guidelines.
JCO oncology practice   15 juin 2020
Pharmacokinetics/pharmacodynamics of liposomal cytarabine (VYXEOS) in AML patients: Influence of cytidine deaminase genetic polymorphisms.
2020 ASCO Annual Meeting I   25 mai 2020
Stability and visual compatibility of daunorubicin and cytarabine during Y-site administration with selected drugs.
2020 ASCO Annual Meeting I   25 mai 2020
Availability of Morphine Oral Solution for Childhood Cancer Patients in Low-Income Countries: Compounding and Stability Study in a Cote d'Ivoire University Teaching Hospital.
Journal of pain and symptom management   24 octobre 2019
Efficacy and safety of autologous stem cell transplantation after induction therapy with lenalidomide, bortezomib, and dexamethasone.
European journal of haematology   07 août 2019